SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Syschem (India) - Quaterly Results

10 Feb 2022 Evaluate
The sales slipped to Rs. 108.96 millions, down -45.60% for the December 2021 quarter as against Rs. 200.30 millions during the year-ago period.The Net Loss for the quarter ended December 2021 is Rs. -9.93 millions as compared to Net Loss of Rs. -15.43 millions of corresponding quarter ended December 2020 Operating profit Margin for the quarter ended December 2021 improved to -3.26% as compared to -9.47% of corresponding quarter ended December 2020


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 108.96 200.30 -45.60 431.15 510.84 -15.60 744.15 880.16 -15.45
Other Income 0.41 0.28 46.43 0.63 1.07 -41.12 2.56 0.90 184.44
PBIDT -3.26 -9.47 -65.58 -22.44 -11.77 90.65 -49.04 -0.33 14760.61
Interest 0.33 0.29 13.79 0.63 0.53 18.87 0.55 0.18 205.56
PBDT -3.59 -9.76 -63.22 -23.07 -12.30 87.56 -49.59 -0.51 9623.53
Depreciation 6.34 5.67 11.82 18.88 17.08 10.54 23.55 21.50 9.53
PBT -9.93 -15.43 -35.64 -41.95 -29.38 42.78 -73.14 -22.01 232.30
TAX 0.00 0.00 0.00 0.00 0.00 0.00 -17.49 -3.47 404.03
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -17.49 -3.47 404.03
PAT -9.93 -15.43 -35.64 -41.95 -29.38 42.78 -55.65 -18.54 200.16
Equity 232.90 215.40 8.12 232.90 215.40 8.12 215.40 187.90 14.64
PBIDTM(%) -2.99 -4.73 -36.72 -5.20 -2.30 125.90 -6.59 -0.04 17473.60

Syschem (India) Share Price

52.87 0.74 (1.42%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×